Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04156997 · ClinicalTrials.gov registry record
Extreme Lipids Repository
A clinical trial of Lipoprotein Disorder, sponsored by University of Texas Southwestern Medical Center.
- Active
- Registry status
- 250
- Enrollment target
- 2
- Study locations
NCT04156997 is a study of Lipoprotein Disorder that is active but no longer recruiting, run by University of Texas Southwestern Medical Center. The registered enrollment target is 250 participants. The trial reports 2 study locations across 1 state.
The verdict
NCT04156997, a study of Lipoprotein Disorder, is active but no longer recruiting, sponsored by University of Texas Southwestern Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- 250 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a prospective, observational study to establish a repository of samples from patients with extreme lipid phenotypes including but not limited to hyperlipidemia, dyslipidemia, hyperlipoproteinemia, extreme low/high HDL levels and deranged lipoprotein metabolism. The investigators plan to conduct sophisticated composition and functional analyses as well as genetic analysis to better understand the determinants of extreme lipid derangements.
Conditions Studied
Interventions
- OTHER No intervention is involved in this study
Study Locations (2)
Texas
- Parkland Health Hospital System - Dallas
- University of Texas Southwestern Medical Center - Ambulatory Clinic - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2019-05-10 |
| Est. Completion | 2029-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04156997
The ClinicalTrials.gov registry entry for NCT04156997 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lipoprotein Disorder appearing as the primary indexed condition, and to 1 intervention - of which No intervention is involved in this study is the first listed.
NCT04156997 reports 2 study locations spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT04156997 about?
NCT04156997 is a clinical study titled "Extreme Lipids Repository". This is a prospective, observational study to establish a repository of samples from patients with extreme lipid phenotypes including but not limited to hyperlipidemia, dyslipidemia, hyperlipoproteinemia, extreme low/high HDL levels and deranged lipoprotein metabolism. The investigators plan to cond...
What is the current status of trial NCT04156997?
This trial is currently active not recruiting. The enrollment target is 250 participants. The study started on 2019-05-10. Estimated completion is 2029-05.
What conditions does trial NCT04156997 study?
This clinical trial studies the following conditions: Lipoprotein Disorder.
What interventions are being tested in trial NCT04156997?
The interventions under investigation include: No intervention is involved in this study (OTHER).
Who is sponsoring clinical trial NCT04156997?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04156997 being conducted?
This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lipoprotein Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.